DE602004024312D1 - Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten - Google Patents

Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten

Info

Publication number
DE602004024312D1
DE602004024312D1 DE602004024312T DE602004024312T DE602004024312D1 DE 602004024312 D1 DE602004024312 D1 DE 602004024312D1 DE 602004024312 T DE602004024312 T DE 602004024312T DE 602004024312 T DE602004024312 T DE 602004024312T DE 602004024312 D1 DE602004024312 D1 DE 602004024312D1
Authority
DE
Germany
Prior art keywords
cxcl6
repair
chemokin
prevention
cartilage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004024312T
Other languages
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tigenix NV
Original Assignee
Tigenix NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135345&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004024312(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tigenix NV filed Critical Tigenix NV
Publication of DE602004024312D1 publication Critical patent/DE602004024312D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602004024312T 2003-08-12 2004-08-12 Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten Active DE602004024312D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49451603P 2003-08-12 2003-08-12
PCT/BE2004/000117 WO2005014026A2 (en) 2003-08-12 2004-08-12 Use of cxcl6 chemokine in the prevention or repair of cartilage defects

Publications (1)

Publication Number Publication Date
DE602004024312D1 true DE602004024312D1 (de) 2010-01-07

Family

ID=34135345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024312T Active DE602004024312D1 (de) 2003-08-12 2004-08-12 Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten

Country Status (16)

Country Link
US (2) US7485310B2 (de)
EP (1) EP1653994B1 (de)
JP (1) JP4920412B2 (de)
AT (1) ATE449608T1 (de)
AU (1) AU2004262451B2 (de)
CA (1) CA2533124C (de)
DE (1) DE602004024312D1 (de)
DK (1) DK1653994T3 (de)
ES (1) ES2337469T3 (de)
HK (1) HK1085656A1 (de)
IL (1) IL173544A (de)
NO (1) NO338152B1 (de)
NZ (1) NZ545702A (de)
PL (1) PL1653994T3 (de)
RU (1) RU2363491C2 (de)
WO (1) WO2005014026A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067123B2 (en) * 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2009076164A2 (en) * 2007-12-05 2009-06-18 Musculoskeletal Transplant Foundation Cancellous bone implant for cartilage repair
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
JP5508421B2 (ja) 2008-09-22 2014-05-28 アルカリオス・ベー・ブイ 薬剤として有用なポリ硫酸カルボキシエチル化シクロデキストリン
GB0820492D0 (en) 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
CA2769326A1 (en) * 2009-07-27 2011-02-10 Baxter International Inc. Blood coagulation protein conjugates
BR112012009540A2 (pt) * 2009-10-23 2019-09-24 Rnl Bio Co Ltd composição e método para induzir a migração de células-tronco adultas derivadas de tecido adiposo
US8687070B2 (en) * 2009-12-22 2014-04-01 Apple Inc. Image capture device having tilt and/or perspective correction
JP6382933B2 (ja) 2013-03-15 2018-08-29 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティドＷ．Ｌ． Ｇｏｒｅ ＆ Ａｓｓｏｃｉａｔｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ 低表面エネルギー構造体用水性送達システム
EP2978452A4 (de) * 2013-03-29 2016-11-02 Merrimack Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung von osteolytischen knochenerkrankungen
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN116904520B (zh) * 2023-09-13 2024-01-09 中国人民解放军军事科学院军事医学研究院 制备重组软骨祖细胞的方法及获得的重组软骨祖细胞与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413511B1 (en) * 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
WO1994012537A2 (en) * 1992-11-27 1994-06-09 Rega Institute Leuven University Granulocyte chemotactic protein
US5723331A (en) * 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
DE19814405C2 (de) * 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US6515001B2 (en) * 2001-03-05 2003-02-04 Chemokine Therapeutic Corporation IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases
CA2458575C (en) * 2001-08-24 2014-07-08 Advanced Cell Technology, Inc. Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
EP1312614A1 (de) 2001-11-16 2003-05-21 GenOdyssee Polynukleotide und Polypeptide des GCP-2 Gens
JP2003199816A (ja) * 2002-01-10 2003-07-15 Takehisa Matsuda 軟骨組織再生用補助材、軟骨組織再生用キット及び軟骨組織再生方法
PL374830A1 (en) * 2002-07-26 2005-10-31 Ajinomoto Co, Inc. Novel peptide synthase gene
PL1649013T3 (pl) * 2003-06-27 2016-07-29 Depuy Synthes Products Inc Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych

Also Published As

Publication number Publication date
US20060246031A1 (en) 2006-11-02
AU2004262451B2 (en) 2009-11-26
CA2533124C (en) 2014-01-28
US7842502B2 (en) 2010-11-30
PL1653994T3 (pl) 2010-05-31
WO2005014026A3 (en) 2005-03-17
US7485310B2 (en) 2009-02-03
NO338152B1 (no) 2016-08-01
NO20060464L (no) 2006-04-20
JP2007501807A (ja) 2007-02-01
US20090117652A1 (en) 2009-05-07
IL173544A0 (en) 2006-07-05
AU2004262451A1 (en) 2005-02-17
CA2533124A1 (en) 2005-02-17
DK1653994T3 (da) 2010-03-15
ES2337469T3 (es) 2010-04-26
EP1653994B1 (de) 2009-11-25
WO2005014026A2 (en) 2005-02-17
RU2363491C2 (ru) 2009-08-10
JP4920412B2 (ja) 2012-04-18
ATE449608T1 (de) 2009-12-15
HK1085656A1 (en) 2006-09-01
RU2006107536A (ru) 2006-08-10
NZ545702A (en) 2008-08-29
IL173544A (en) 2013-12-31
EP1653994A2 (de) 2006-05-10

Similar Documents

Publication Publication Date Title
NO20060464L (no) Use of CXCL6 chemokine in the prevention or repair of cartilage defects
ATE435656T1 (de) Nkg2d modulation
BRPI0619579B8 (pt) Métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse
DE60031419D1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
DE602005023181D1 (de) Lentivirusvektoren und deren verwendung
CY1109267T1 (el) Μεθοδοι για την καλλιεργεια κυκλοϊου
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
HK1115590A1 (en) Triazolophthalazines
DK1737950T3 (da) Celler, der udviser neuronal-progenitorcelle-karakteristika
DE602005017135D1 (de) Neue verwendung von pde5-hemmern
ATE556137T1 (de) Durch einen polyelektrolytkomplex von hyaluronsäure und chitosan verstärkte biomimetische zusammensetzung
DE602004026445D1 (de) Verwendung von cardiotrophin zur modulation der stammzellenproliferation
DK1587526T3 (da) MNTF-peptider og sammensætninger og anvendelsesmåder
WO2003059932A3 (en) Methods of inducing or enhancing connective tissue repair
TW200643169A (en) The preparation of multipotent stem cells and the use thereof
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
DE60225530D1 (de) Phosphorylierte glyoxalase i und deren verwendung
GB0720502D0 (en) Markers of matrix gene expression and cellular differentiation in chondrocytes
ATE374243T1 (de) Knorpelzell-kulturmedium und verwendung desselben
BRPI0415446A (pt) recombinação mediada por flp
ATE464316T1 (de) Transiente immortalisierung von zellen durch onkogenproteine oder telomerproteine
ATE449863T1 (de) Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese
MY179011A (en) Tissue-engineered articular cartilage
MY171579A (en) Construction of tissue-engineered bone using ceramic scaffold and fibrin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition